Expert Reviews: 5 Ways Trump’s FDA May Skip Drug Trials
Under Trump, the FDA is seeking to abandon traditional expert reviews for new drugs. Find out how this major policy shift could impact public health and safety.
Under Trump, the FDA is seeking to abandon traditional expert reviews for new drugs. Find out how this major policy shift could impact public health and safety.